Optimal strategies of social distancing and vaccination against seasonal influenza

Eunha Shim

doi:10.3934/mbe.2013.10.1615

Article Contents

2013, Volume 10, Issue 5&6: 1615-1634. Doi: 10.3934/mbe.2013.10.1615 open access

This issue Previous Article Carlos Castillo-Chavez: A century ahead Next Article Chemostats and epidemics: Competition for nutrients/hosts

Optimal strategies of social distancing and vaccination against seasonal influenza

Eunha Shim^1,

1.
Department of Mathematics, University of Tulsa, Tulsa, OK 74104

Received: October 2012

Revised: March 2013

Published: August 2013

Abstract / Introduction Related Papers Cited by

Abstract

Optimal control strategies for controlling seasonal influenza transmission in the US are of high interest, because of the significant epidemiological and economic burden of influenza. To evaluate optimal strategies of vaccination and social distancing, we used an age-structured dynamic model of seasonal influenza. We applied optimal control theory to identify the best way of reducing morbidity and mortality at a minimal cost. In combination with the Pontryagins maximum principle, we calculated time-dependent optimal policies of vaccination and social distancing to minimize the epidemiological and economic burden associated with seasonal influenza. We computed optimal age-specific intervention strategies and analyze them under various costs of interventions and disease transmissibility. Our results show that combined strategies have a stronger impact on the reduction of the final epidemic size. Our results also suggest that the optimal vaccination can be achieved by allocating most vaccines to preschool-age children (age under five) followed by young adults (age 20-39) and school age children (age 6-19). We find that the optimal vaccination rates for all age groups are highest at the beginning of the outbreak, requiring intense effort at the early phase of an epidemic. On the other hand, optimal social distancing of clinical cases tends to last the entire duration of an outbreak, and its intensity is relatively equal for all age groups. Furthermore, with higher transmissibility of the influenza virus (i.e. higher R0), the optimal control strategy needs to include more efforts to increase vaccination rates rather than efforts to encourage social distancing. Taken together, public health agencies need to consider both the transmissibility of the virus and ways to encourage early vaccination as well as voluntary social distancing of symptomatic cases in order to determine optimal intervention strategies against seasonal influenza.

Keywords:

Mathematics Subject Classification: Primary: 49J15, 62P10.

Citation:

Related Papers

Cited by

References

[1]	R. M. Anderson and R. M. May, "Infectious Diseases of Humans,'' Oxford University Press, Oxford, 1991.doi: 10.1016/0046-8177(90)90224-S.
[2]	H. Behnke, Optimal control of deterministic epidemics, Optimal Control Application Methods, 21 (2000), 269-285.doi: 10.1002/oca.678.
[3]	K. J. Bolton, J. M. McCaw, R. Moss, R. S. Morris, S. Wang, A. Burma, B. Darma, D. Narangerel, P. Nymadawa and J. McVernon, Likely effectiveness of pharmaceutical and non-pharmaceutical interventions for mitigating influenza virus transmission in Mongolia, Bull World Health Organization, 90 (2012), 264-271.
[4]	F. Brauer and C. Castillo-Chavez, "Mathematical Models in Population Biology and Epidemiology,'' $2^{nd}$ edition, Texts in Applied Mathematics, 40, Springer, New York, 2012.doi: 10.1007/978-1-4614-1686-9.
[5]	J. S. Brownstein, K. P. Kleinman and K. D. Mandl, Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system, Am. J. Epidemiol, 162 (2005), 1-8.doi: 10.1093/aje/kwi257.
[6]	K. M. Clements, J. Chancellor, K. Nichol, K. DeLong and D. Thompson, Cost-effectiveness of a recommendation of universal mass vaccination for seasonal influenza in the United States, Value Health, 14 (2011), 800-811.doi: 10.1016/j.jval.2011.03.005.
[7]	G. Chowell, C. Viboud, X. Wang, S. M. Bertozzi and M. A. Miller, Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study, PLoS One, 4 (2009), e8164.doi: 10.1371/journal.pone.0008164.
[8]	O. Diekmann and J. Heesterbeek, "Mathematical Epidmeiology of Infectious Diseases: Model Building, Analysis and Interpretation,'' Wiley Series in Mathematical and Computational Biology, John Wiley & Sons, Ltd., Chichester, 2000.
[9]	H. P. Duerr, S. O. Brockmann, I. Piechotowski, M. Schwehm and M. Eichner, Influenza pandemic intervention planning using InfluSim: Pharmaceutical and non-pharmaceutical interventions, BMC Infect. Dis., 7 (2007).doi: 10.1186/1471-2334-7-76.
[10]	W. H. Fleming and R. W. Rishel, "Deterministic and Stochastic Optimal Control,'' Applications of Mathematics, No. 1, Springer-Verlag, Berlin-New York, 1975.
[11]	A. P. Galvani, T. C. Reluga and G. B. Chapman, Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum, Proc. Natl. Acad. Sci. USA, 104 (2007), 5692-5697.doi: 10.1073/pnas.0606774104.
[12]	R. Gasparini, D. Amicizia, P. L. Lai and D. Panatto, Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly, Hum. Vaccin. Immunother., 8 (2012), 21-28.doi: 10.4161/hv.8.1.17622.
[13]	R. J. Glass, L. M. Glass, W. E. Beyeler and H. J. Min, Targeted social distancing design for pandemic influenza, Emerg. Infect. Dis., 12 (2006), 1671-1681.doi: 10.3201/eid1211.060255.
[14]	J. Glasser, Z. Feng, A. Moylan, S. Del Valle and C. Castillo-Chavez, Mixing in age-structured population models of infectious diseases, Math. Biosci., 235 (2012), 1-7.doi: 10.1016/j.mbs.2011.10.001.
[15]	J. Glasser, D. Taneri, Z. Feng, J. H. Chuang, P. Tll, W. Thompson, M. McCauley and J. Alexander, Evaluation of targeted influenza vaccination strategies via population modeling, PLoS One, 5 (2010), e12777.doi: 10.1371/journal.pone.0012777.
[16]	P. A. Gonzalez-Parra, S. Lee, L. Velazquez and C. Castillo-Chavez, A note on the use of optimal control on a discrete time model of influenza dynamics, Math. Biosci. Eng., 8 (2011), 183-197.doi: 10.3934/mbe.2011.8.183.
[17]	T. M. Govaert, C. T. Thijs, N. Masurel, M. J. Sprenger, G. J. Dinant and J. A. Knottnerus, The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial, JAMA, 272 (1994), 1661-1665.
[18]	P. A. Gross, A. W. Hermogenes, H. S. Sacks, J. Lau and R. A. Levandowski, The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature, Ann. Intern. Med., 123 (1995), 518-527.doi: 10.7326/0003-4819-123-7-199510010-00008.
[19]	N. Halder, J. K. Kelso and G. J. Milne, Cost-effective strategies for mitigating a future influenza pandemic with H1N1 2009 characteristics, PLoS One, 6 (2011), e22087.doi: 10.1371/journal.pone.0022087.
[20]	J. S. Horvath, M. McKinnon and L. Roberts, The Australian response: Pandemic influenza preparedness, Med. J. Aust., 185 (2006), S35-8.
[21]	M. J. Keeling and L. Danon, Mathematical modelling of infectious diseases, Br. Med. Bull., 92 (2009), 33-42.doi: 10.1093/bmb/ldp038.
[22]	M. J. Keeling and P. J. White, Targeting vaccination against novel infections: Risk, age and spatial structure for pandemic influenza in Great Britain, J. R. Soc. Interface, 8 (2011), 661-670.doi: 10.1098/rsif.2010.0474.
[23]	J. K. Kelso, G. J. Milne and H. Kelly, Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of influenza, BMC Public Health, 9 (2009).doi: 10.1186/1471-2458-9-117.
[24]	S. Lee, G. Chowell and C. Castillo-Chavez, Optimal control for pandemic influenza: The role of limited antiviral treatment and isolation, J. Theor. Biol., 265 (2010), 136-150.doi: 10.1016/j.jtbi.2010.04.003.
[25]	S. Lee, M. Golinski and G. Chowell, Modeling optimal age-specific vaccination strategies against pandemic influenza, Bull. Math. Biol., 74 (2012), 958-980.doi: 10.1007/s11538-011-9704-y.
[26]	S. Lee, R. Morales and C. Castillo-Chavez, A note on the use of influenza vaccination strategies when supply is limited, Math. Biosci. Eng., 8 (2011), 171-182.doi: 10.3934/mbe.2011.8.171.
[27]	V. J. Lee, D. C. Lye and A. Wilder-Smith, Combination strategies for pandemic influenza response - a systematic review of mathematical modeling studies, BMC Med., 7 (2009).doi: 10.1186/1741-7015-7-76.
[28]	S. Lenhart and J. T. Workman, "Optimal Control Applied to Biological Models,'' Chapman & Hall/CRC Mathematical and Computational Biology Series, Chapman & Hall/CRC, Boca Raton, FL, 2007.
[29]	F. Lin, K. Muthuraman and M. Lawley, An optimal control theory approach to non-pharmaceutical interventions, BMC Infect. Dis., 10 (2010).doi: 10.1186/1471-2334-10-32.
[30]	I. M. Longini, Jr. and M. E. Halloran, Strategy for distribution of influenza vaccine to high-risk groups and children, Am. J. Epidemiol., 161 (2005), 303-306.
[31]	A. M. McBean and P. L. Hebert, New estimates of influenza-related pneumonia and influenza hospitalizations among the elderly, Int. J. Infect. Dis., 8 (2004), 227-235.doi: 10.1016/j.ijid.2004.04.013.
[32]	J. Medlock and A. P. Galvani, Optimizing influenza vaccine distribution, Science, 325 (2009), 1705-1708.doi: 10.1126/science.1175570.
[33]	G. N. Mercer, S. I. Barry and H. Kelly, Modelling the effect of seasonal influenza vaccination on the risk of pandemic influenza infection, BMC Public Health, 11 (2011), S11.doi: 10.1186/1471-2458-11-S1-S11.
[34]	S. M. Moghadas, C. S. Bowman, G. Rst and J. Wu, Population-wide emergence of antiviral resistance during pandemic influenza, PLoS One, 3 (2008), e1839.doi: 10.1371/journal.pone.0001839.
[35]	N. A. Molinari, I. R. Ortega-Sanchez, M. L. Messonnier, W. W. Thompson, P. M. Wortley, E. Weintraub and C. B. Bridges, The annual impact of seasonal influenza in the US: Measuring disease burden and costs, Vaccine, 25 (2007), 5086-5096.doi: 10.1016/j.vaccine.2007.03.046.
[36]	S. D. Mylius, T. J. Hagenaars, A. K. Lugnr and J. Wallinga, Optimal allocation of pandemic influenza vaccine depends on age, risk and timing, Vaccine, 26 (2008), 3742-3749.doi: 10.1016/j.vaccine.2008.04.043.
[37]	H. Nishiura, C. Castillo-Chavez, M. Safan and G. Chowell, Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan, Euro. Surveill., 14 (2009), 19227.
[38]	L. S. Pontryagin, V. G. Boltyanskii, R. V. Gamkrelidze and E. F. Mishchenko, "The Mathematical Theory of Optimal Processes,'' Interscience Publishers John Wiley & Sons, Inc., New York-London, 1962.
[39]	O. Prosper, O. Saucedo, D. Thompson, G. Torres-Garcia, X. Wang and C. Castillo-Chavez, Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza, Math. Biosci. Eng., 8 (2011), 141-170.doi: 10.3934/mbe.2011.8.141.
[40]	E. Shim, L. A. Meyers and A. P. Galvani, Optimal H1N1 vaccination strategies based on self-interest versus group interest, BMC Public Health, 11 (2011), S4.doi: 10.1186/1471-2458-11-S1-S4.
[41]	L. Simonsen, T. A. Reichert, C. Viboud, W. C. Blackwelder, R. J. Taylor and M. A. Miller, Impact of influenza vaccination on seasonal mortality in the US elderly population, Arch. Intern. Med., 165 (2005), 265-272.
[42]	J. M. Tchuenche, S. A. Khamis, F. B. Agusto and S. C. Mpeshe, Optimal control and sensitivity analysis of an influenza model with treatment and vaccination, Acta Biotheor, 59 (2011), 1-28.doi: 10.1007/s10441-010-9095-8.
[43]	W. W. Thompson, D. K. Shay, E. Weintraub, L. Brammer, C. B. Bridges, N. J. Cox and K. Fukuda, Influenza-associated hospitalizations in the United States, JAMA, 292 (2004), 1333-1340.doi: 10.1001/jama.292.11.1333.
[44]	W. W. Thompson, D. K. Shay, E. Weintraub, L. Brammer, N. Cox, L. J. Anderson and K. Fukuda, Mortality associated with influenza and respiratory syncytial virus in the United States, JAMA, 289 (2003), 179-186.doi: 10.1001/jama.289.2.179.
[45]	S. Towers and Z. Feng, Social contact patterns and control strategies for influenza in the elderly, Math. Biosci., 240 (2012), 241-249.doi: 10.1016/j.mbs.2012.07.007.
[46]	J. Truscott, C. Fraser, S. Cauchemez, A. Meeyai, W. Hinsley, C. A. Donnelly, A. Ghani and N. Ferguson, Essential epidemiological mechanisms underpinning the transmission dynamics of seasonal influenza, J. R. Soc. Interface, 9 (2012), 304-312.doi: 10.1098/rsif.2011.0309.
[47]	A. R. Tuite, D. N. Fisman, J. C. Kwong and A. L. Greer, Optimal pandemic influenza vaccine allocation strategies for the Canadian population, PLoS One, 5 (2010), e10520.doi: 10.1371/journal.pone.0010520.
[48]	P. van den Driessche and J. Watmough, Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission, Math. Biosci., 180 (2002), 29-48.doi: 10.1016/S0025-5564(02)00108-6.
[49]	J. Wallinga and P. Teunis, Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures, Am. J. Epidemiol., 160 (2004), 509-516.doi: 10.1093/aje/kwh255.
[50]	J. Wallinga, P. Teunis and M. Kretzschmar, Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents, Am. J. Epidemiol., 164 (2006), 936-944.doi: 10.1093/aje/kwj317.
[51]	D. Weycker, J. Edelsberg, M. E. Halloran, I. M. Longini, Jr., A. Nizam, V. Ciuryla and G. Oster, Population-wide benefits of routine vaccination of children against influenza, Vaccine, 23 (2005), 1284-1293.doi: 10.1016/j.vaccine.2004.08.044.
[52]	J. T. Wu and B. J. Cowling, The use of mathematical models to inform influenza pandemic preparedness and response, Exp. Biol. Med. (Maywood), 236 (2011), 955-961.doi: 10.1258/ebm.2010.010271.
[53]	P. Zhang and P. M. Atkinson, Modelling the effect of urbanization on the transmission of an infectious disease, Math. Biosci., 211 (2008), 166-185.doi: 10.1016/j.mbs.2007.10.007.
[54]	U.S. Census Bureau, International Data Base. Available from: http://www.census.gov/population/international/data/idb/region.php.
[55]	Centers For Disease Control and Prevention, Large-scale vaccination clinic output and staffing estimates: An example, (2009). Available from: http://www.cdc.gov/h1n1flu/vaccination/pdf/A-Wortley-H1N1-sample-clinic.pdf.
[56]	Centers For Disease Control and Prevention, Use of influenza A (H1N1) 2009 monovalent vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009, MMWR Recomm. Rep., 58(RR-10) (2009), 1-8.
[57]	Centers For Disease Control and Prevention, Preventing emerging infectious diseases: A strategy for the 21st century. Overview of the updated CDC plan, MMWR Recomm. Rep., 47(RR-15) (1998), 1-14.